semaglutide tirzepatide comparison AOD-9604 vs MOTS-c vs Tesamorelin vs vs Cardiovascular outcomes of semaglutide and

Generic semaglutide is authorised by Health Canada for the management of type 2 diabetes, though it may be prescribed off-label for weight management at a licensed provider's clinical discretion

Since then, Wegovy has gained additional approvals for use in pediatric patients aged 12 and older with obesity and to reduce the risk of MACE in adults with established cardiovascular disease who are overweight or obese

PBS listing, which is what makes a drug affordable in Australia, adds another 12 to 24 months on top of TGA approval

CBT-I ushers in a new level of promise for patients with insomnia as a true treatment that is non-invasive and free of pharmacological interactions